Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis

Archive ouverte

Guyon, Joris | Fernandez-Moncada, Ignacio | Larrieu, Claire | Bouchez, Cyrielle | Pagano Zottola, Antonio | Galvis, Johanna | Chouleur, Tiffanie | Burban, Audrey | Joseph, Kevin | Ravi, Vidhya | Espedal, Heidi | Røsland, Gro Vatne | Daher, Boutaina | Barre, Aurélien | Dartigues, Benjamin | Karkar, Slim | Rudewicz, Justine | Romero-Garmendia, Irati | Klink, Barbara | Grützmann, Konrad | Derieppe, Marie‐alix | Molinié, Thibaut | Obad, Nina | Léon, Céline | Seano, Giorgio | Miletic, Hrvoje | Heiland, Dieter Henrik | Marsicano, Giovanni | Nikolski, Macha | Bjerkvig, Rolf | Bikfalvi, Andreas | Daubon, Thomas

Edité par CCSD ; Wiley Open Access -

International audience. Abstract Lactate is a central metabolite in brain physiology but also contributes to tumor development. Glioblastoma (GB) is the most common and malignant primary brain tumor in adults, recognized by angiogenic and invasive growth, in addition to its altered metabolism. We show herein that lactate fuels GB anaplerosis by replenishing the tricarboxylic acid (TCA) cycle in absence of glucose. Lactate dehydrogenases (LDHA and LDHB), which we found spatially expressed in GB tissues, catalyze the interconversion of pyruvate and lactate. However, ablation of both LDH isoforms, but not only one, led to a reduction in tumor growth and an increase in mouse survival. Comparative transcriptomics and metabolomics revealed metabolic rewiring involving high oxidative phosphorylation (OXPHOS) in the LDHA/B KO group which sensitized tumors to cranial irradiation, thus improving mouse survival. When mice were treated with the antiepileptic drug stiripentol, which targets LDH activity, tumor growth decreased. Our findings unveil the complex metabolic network in which both LDHA and LDHB are integrated and show that the combined inhibition of LDHA and LDHB strongly sensitizes GB to therapy.

Suggestions

Du même auteur

Specific expression of lactate dehydrogenases in glioblastoma controls intercellular lactate transfer to promote tumor growth and invasion

Archive ouverte | Guyon, Joris | CCSD

Abstract Lactate is a central metabolite in brain physiology, involved in the astrocyte-neuron lactate shuttle, but also contributes to tumor development. Glioblastoma (GBM) is the most common and malignant primary brain tumor in ...

Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-Penetrant Drug with a Safe Profile

Archive ouverte | Burban, Audrey | CCSD

Prépublication. Glioblastoma (GB) remains one of the most treatment refractory and fatal tumour in humans. GB contains a population of self-renewing stem cells, the brain tumour stem cells (BTSC) that are highly res...

Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile

Archive ouverte | Burban, Audrey | CCSD

International audience. Glioblastoma is one of the most treatment-resistant and lethal cancers, with a subset of self-renewing brain tumour stem cells (BTSCs), driving therapy resistance and relapse. Here, we report...

Chargement des enrichissements...